Finlay Institute
Jump to navigation
Jump to search
 | This article relies largely or entirely on a single source. (July 2021) |
| File:Finlay Institute logo.png | |
| Established | 1991 |
|---|---|
| Staff | 970 (2014)[1] |
| Address | Avenida 21 No. 19810 |
| Location | , Cuba |
| Coordinates | Lua error in Module:Coordinates at line 489: attempt to index field 'wikibase' (a nil value). |
| Lua error in Module:Infobox_mapframe at line 197: attempt to index field 'wikibase' (a nil value). | |
| Website | www |
The Finlay Institute (Spanish: Instituto Finlay de Vacunas, lit. 'Finlay Vaccine Institute') is a Cuban organization that carries out medical research and mainly produces vaccines. It is named after the Cuban doctor Carlos Finlay, who was the first to hypothesize the involvement of a mosquito as a vector of yellow fever.[2]
In response to fight against COVID-19, Finlay Institute has developed the Soberana 02.[3] In March 2021, Vicente Vérez, director of the Finlay Institute, announced a delay in the development of vaccines and indicated the start of vaccination of the Cuban population in July 2021.[4]
References
[edit | edit source]- ^ Cuba's Maternal-Child Health - Scholar Works at UT Tyler
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Cuba pospone el inicio de la vacunación con Soberana 14ymedio, 8 mars 2021
Lua error in Module:Authority_control at line 153: attempt to index field 'wikibase' (a nil value).
